The United States Patent and Trademark Office (USPTO) has granted patent US12582601B2 to BIOPHARMA SYNERGIES, S.L. for an orodispersible powder composition. The patent specifically claims a formulation containing an active pharmaceutical ingredient combined with a ternary synergistic blend of sodium citrate, citric acid, and sucralose. The grant also extends to stick packs and tablets incorporating this composition, as well as their therapeutic applications.

This patent grant represents a new intellectual property right for the assignee, potentially impacting market exclusivity for specific drug formulations. While not a regulatory rule imposing obligations on other entities, it signifies a new development in pharmaceutical composition technology. Compliance officers in the pharmaceutical sector should be aware of this patent as it may affect product development, licensing, and freedom-to-operate analyses for similar orodispersible formulations.